FDA RETALIATION ALLEGATIONS SHOULD BE INVESTIGATED THROUGH "INDEPENDENT" OUTSIDE PROCESS, REP. BARTON TELLS KESSLER AT OVERSIGHT SUBCOMMITTEE HEARING
Rep. Barton (R-Tex.) will push for an outside investigative body to handle allegations of retaliation as an element of FDA reform legislation.
You may also be interested in...
A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011